A new sickle cell disease therapy offers hope for Senegal and Africa, where nearly 400,000 children are born annually with this serious genetic disease.
This innovative treatment could transform the medical management of the disease and opens perspectives for significant improvement for African patients.
The initiative illustrates advances in African medical research against genetic diseases specific to the continent.